Incidence and outcome of infection by vancomycin-resistant Enterococcus following orthotopic liver transplantation

被引:68
作者
Newell, KA
Millis, JM
Arnow, PM
Bruce, DS
Woodle, ES
Cronin, DC
Loss, GE
Grewal, H
Lissoos, T
Schiano, T
Mead, J
Thistlethwaite, JR
机构
[1] Univ Chicago, Dept Surg, Sect Transplantat, Chicago, IL 60637 USA
[2] Univ Chicago, Dept Med, Chicago, IL 60637 USA
[3] Univ Chicago, Dept Pharm, Chicago, IL 60637 USA
关键词
D O I
10.1097/00007890-199802150-00027
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Vancomycin resistant Enterococcus (VRE) has become a significant nosocomial pathogen, For this study, the records of 325 patients who underwent orthotopic liver transplantation (OLT) were reviewed, Thirty-four patients were infected by VRE (incidence of 10.5%, 14% in adults vs. 5% in children, P<0.01), Common features of patients who developed infections with VRE included previous antibiotic use (25 patients, 15 of whom received vancomycin), co-infection by other pathogens (28 patients), and relaparotomy following OLT (20 patients). Pulmonary and/or renal failure preceded infection by VRE in 11 and 4 adult patients, respectively. Biliary complications were exceedingly common in patients infected by VRE (28 patients) and significantly increased the risk of infection by VRE (21.5% vs, 3.1% for patients without biliary complications, P<0.0001). Mortality associated with VRE infections was high (56% vs. 19% for patients not infected by VRE, P<0.0005), The most frequent cause of death was sepsis (16 of 19 patient deaths), often polymicrobial, The high incidence of infection by VRE following OLT, the lack of effective antibiotics for the treatment of VRE, and the association of VRE with patient mortality emphasizes the need to define the risk factors associated with VRE infection, We suggest early surgical intervention to treat complications that may predispose patients to infection by VRE.
引用
收藏
页码:439 / 442
页数:4
相关论文
共 10 条
[1]   Epidemiology of colonisation of patients and environment with vancomycin-resistant enterococci [J].
Bonten, MJM ;
Hayden, MK ;
Nathan, C ;
vanVoorhis, J ;
Matushek, M ;
Slaughter, S ;
Rice, T ;
Weinstein, RA .
LANCET, 1996, 348 (9042) :1615-1619
[2]   INFECTIONS IN RECIPIENTS OF LIVER HOMOGRAFTS [J].
FULGINITI, VA ;
SCRIBNER, R ;
GROTH, CG ;
PUTNAM, CW ;
BRETTSCHNEIDER, L ;
GILBERT, S ;
PORTER, KA ;
STARZL, TE .
NEW ENGLAND JOURNAL OF MEDICINE, 1968, 279 (12) :619-+
[3]   CDC DEFINITIONS FOR NOSOCOMIAL INFECTIONS, 1988 [J].
GARNER, JS ;
JARVIS, WR ;
EMORI, TG ;
HORAN, TC ;
HUGHES, JM .
AMERICAN JOURNAL OF INFECTION CONTROL, 1988, 16 (03) :128-140
[4]  
GEORGE DL, 1991, REV INFECT DIS, V13, P387
[5]   RECOVERY OF VANCOMYCIN-RESISTANT GRAM-POSITIVE COCCI FROM PEDIATRIC LIVER-TRANSPLANT RECIPIENTS [J].
GREEN, M ;
BARBADORA, K ;
MICHAELS, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 1991, 29 (11) :2503-2506
[6]   Differences in outcomes for patients with bacteremia due to vancomycin-resistant Enterococcus faecium or vancomycin-susceptible E-faecium [J].
Linden, PK ;
Pasculle, AW ;
Manez, R ;
Kramer, DJ ;
Fung, JJ ;
Pinna, AD ;
Kusne, S .
CLINICAL INFECTIOUS DISEASES, 1996, 22 (04) :663-670
[7]  
Mainous MR, 1997, ARCH SURG-CHICAGO, V132, P76
[8]   Nosocomial infections with vancomycin-resistant Enterococcus faecium in liver transplant recipients: Risk factors for acquisition and mortality [J].
Papanicolaou, GA ;
Meyers, BR ;
Meyers, J ;
Mendelson, MH ;
Lou, W ;
Emre, S ;
Sheiner, P ;
Miller, C .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (04) :760-766
[9]  
SCHROTER GPJ, 1976, ARCH SURG-CHICAGO, V111, P1337
[10]  
UTTLEY AHC, 1988, LANCET, V1, P57